Ming Yu

Ming Yu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Neuroscience Letters
Verified
Journal Article
Closed access
SCSiyuan Chen
Siyuan Chen
YLYueqin Liu
Yueqin Liu
YNYuanyuan Niu
Yuanyuan Niu
YXYuhao Xu
Yuhao Xu
QZQianwen Zhou
Qianwen Zhou
MYMing Yu
Ming Yu

1 May 2018 in Neuroscience
Verified
Journal Article
Closed access
HWHong Wei
Hong Wei
YXYuhao Xu
Yuhao Xu
WXWenlin Xu
Wenlin Xu
QZQianwen Zhou
Qianwen Zhou
QCQi Chen
Qi Chen
YLYuefeng Li
Yuefeng Li

26 January 2022 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
YLYan Liu
Yan Liu
YXYuhao Xu
Yuhao Xu
MYMing Yu
Ming Yu
The aim of the present study was to investigate the expression levels of microRNA(miR)‑4722‑5p and miR‑615‑3p in Alzheimer's disease (AD) and their diagnostic value. Blood samples were collected from 33 patients with AD and 33 healthy controls, and an β‑amyloid (Aβ)25‑35‑induced PC12 cell model was also established. The relative mRNA expression levels of miR‑4722‑5p and miR‑615‑3p were detected using reverse transcription‑quantitative PCR. The correlations between the mRNA expression levels of the two miRNAs and the mini‑mental state examination (MMSE) scores were analyzed, and the receiver operating characteristic curve was used to assess the diagnostic value of miR‑4722‑5p and miR‑615‑3p in AD. Functional enrichment analysis of the miRNA target genes was performed using The Database for Annotation, Visualization and Integrated Discovery database and the R language analysis package. The mRNA expression levels of miR‑4722‑5p and miR‑615‑3p were increased in patients with AD and the Aβ25‑35‑induced PC12 cell model. The mRNA expression levels of miR‑4722‑5p and miR‑615‑3p were negatively correlated with MMSE scores, and the combination of the two miRNAs for AD had an improved diagnostic value than that of each miRNA alone. The results of Gene Ontology (GO) enrichment analysis showed that the target genes of miR‑4722‑5p were found in the cytoplasm and cytosol, and were mainly involved in protein folding and cell division. The molecular functions included protein binding and GTPase activator activity. The results of Kyoto Encyclopedia of Genes and Genomes analysis showed that miR‑4722‑5p was associated with the regulation of dopaminergic synapses and mTOR signaling pathways. GO enrichment analysis also revealed that the target genes of miR‑615‑3p were located in the nucleus and cytoplasm, were involved in the regulation of transcription and protein phosphorylation, and were associated with protein binding, metal ion binding and transcription factor activity. The target genes of miR‑615‑3p played important roles in the regulation of the Ras and FoxO signaling pathways. In conclusion, miR‑4722‑5p and miR‑615‑3p may be potential biomarkers in the early diagnosis of AD.

1 May 2019 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YXYuhao Xu
Yuhao Xu
HWHong Wei
Hong Wei
YZYuanyuan Zhu
Yuanyuan Zhu
YZYan Zhu
Yan Zhu
NZNingning Zhang
Ningning Zhang
YLYuefeng Li
Yuefeng Li

26 April 2017 in Clinical Proteomics
Verified
Journal Article
Open access
PDF file
GLGuo-Chun Li
Guo-Chun Li
LZLina Zhang
Lina Zhang
MYMing Yu
Ming Yu
HJHaiyu Jia
Haiyu Jia
TTTing Tian
Ting Tian
LZLing Zhou
Ling Zhou
The systematic mechanisms of acute intracerebral hemorrhage are still unknown and unverified, although many recent researches have indicated the secondary insults. This study was aimed to disclose the pathological mechanism and identify novel biomarker and therapeutic target candidates by plasma proteome. Patients with AICH (n = 8) who demographically matched healthy controls (n = 4) were prospectively enrolled, and their plasma samples were obtained. The TMT-LC–MS/MS-based proteomics approach was used to quantify the differential proteome across plasma samples, and the results were analyzed by Ingenuity Pathway Analysis to explore canonical pathways and the relationship involved in the uploaded data. Compared with healthy controls, there were 31 differentially expressed proteins in the ICH group (P < 0.05), of which 21 proteins increased while 10 proteins decreased in abundance. These proteins are involved in 21 canonical pathways. One network with high confidence level was selected by the function network analysis, in which 23 proteins, P38MAPK and NFκB signaling pathways participated. Upstream regulator analysis found two regulators, IL6 and TNF, with an activation z-score. Seven biomarker candidates: APCS, FGB, LBP, MGMT, IGFBP2, LYZ, and APOA4 were found. Six candidate proteins were selected to assess the validity of the results by subsequent Western blotting analysis. Our analysis provided several intriguing pathways involved in ICH, like LXR/RXR activation, acute phase response signaling, and production of NO and ROS in macrophages pathways. The three upstream regulators: IL-6, TNF, LPS, and seven biomarker candidates: APCS, APOA4, FGB, IGFBP2, LBP, LYZ, and MGMT were uncovered. LPS, APOA4, IGFBP2, LBP, LYZ, and MGMT are novel potential biomarkers in ICH development. The identified proteins and pathways provide new perspectives to the potential pathological mechanism and therapeutic targets underlying ICH.

3 March 2025 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
GJGuimin Jin
Guimin Jin
WHWei Han
Wei Han
TDTingting Duan
Tingting Duan
ZXZongwei Xue
Zongwei Xue
CSChenglin Song
Chenglin Song
MYMing Yu
Ming Yu